Alamar Biosciences, Inc. (California) (ALMR)

30.25 +2.20 (+7.84%) USD  |  NASDAQ  |  Nov 09, 10:17
More

Alamar Biosciences Capital Expenditures (TTM)

Capital Expenditures (TTM) Chart

View Capital Expenditures (TTM) for ALMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Capital Expenditures (TTM) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --

Capex Definition

Capital expenditures are a line item from a company's statement of cash flows.

Read full definition.

Capital Expenditures (TTM) Range, Past 5 Years

View Capital Expenditures (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Capital Expenditures (TTM) Benchmarks

View Capital Expenditures (TTM) Benchmarks
Start Trial
Personalis, Inc. Upgrade
10X Genomics, Inc. Upgrade
Champions Oncology, Inc. Upgrade
Medpace Holdings, Inc. Upgrade
Avantor, Inc. Upgrade